![1-{1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimida…](https://static.cymitquimica.com/cas-image/298947-1-1-4-6-phenyl-1h-imidazo-45-g-quinoxalin-7-yl-benzyl-piperidin-4-yl-13-dihydro-2h-benzimidazol-2-one.png)
CAS: 612847-09-3 - 1-{1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
Formula:C34H29N7O
InChI:InChI=1/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25H,14-17,20H2,(H,35,36)(H,39,42)
- Synonyms:
- 1-{1-[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
- 2H-benzimidazol-2-one, 1,3-dihydro-1-[1-[[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]-4-piperidinyl]-
- 3-[1-[[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one
- Akti-1/2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AKT inhibitor VIII REF: TM-T3346CAS: 612847-09-3 | 98.65% - 98.77% | 52.00 €~627.00 € | Thu 16 Jan 25 |
 | Akti-1/2 REF: 4Z-K-031076CAS: 612847-09-3 | - - - | To inquire | Thu 16 Jan 25 |
 | Akti-1/2 REF: 3D-FA17246CAS: 612847-09-3 | Min. 95% | To inquire | Thu 20 Feb 25 |
 | AKTI-1/2 REF: IN-DA00ECCOCAS: 612847-09-3 | 97% | - - - | Discontinued product |
 | Akti-1/2 REF: TR-A450300CAS: 612847-09-3 | - - - | - - - | Discontinued product |
AKT inhibitor VIII
CAS:612847-09-3
AKT inhibitor VIII (AKTi-1/2) is a highly specific Akt1/2 inhibitor (IC50: 58/210 nM). The selectivity …
Formula:
C34H29N7O
Purity:
98.65% - 98.77%
Color and Shape:
Pale Yellow Solid
Molecular weight:
551.64
Ref: TM-T3346
| 1mg | 52.00 € | ||
| 2mg | 66.00 € | ||
| 5mg | 103.00 € | ||
| 10mg | 149.00 € | ||
| 25mg | 259.00 € | ||
| 50mg | 425.00 € | ||
| 100mg | 627.00 € | ||
| 1mL*10mM (DMSO) | 126.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Ref: 4Z-K-031076
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025
Akti-1/2
Controlled ProductCAS:612847-09-3
Akti-1/2 is a potential anticancer agent that inhibits growth and induces apoptosis in cancer cells. …
Formula:
C34H29N7O
Purity:
Min. 95%
Molecular weight:
551.64 g/mol
Ref: 3D-FA17246
| 5mg | 338.00 € | ||
| 10mg | 475.00 € | ||
| 25mg | 775.00 € |
Estimated delivery in United States, on Thursday 20 Feb 2025
Ref: IN-DA00ECCO
| 5mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information |
Akti-1/2
CAS:612847-09-3
Applications Allosteric Akt (PKB) inhibitors used in synergistic combination therapy for the treatment of cancer.
Formula:
C34H29N7O
Color and Shape:
Pale Yellow Solid
Molecular weight:
551.64
Ref: TR-A450300
| 1mg | Discontinued | Request information |
